Prosecution Insights
Last updated: October 26, 2026

Alicia L Otton, USPTO Patent Examiner

Listed by the USPTO as OTTON, ALICIA L

Tech Center 4100 • Art Units: 1623 1625 1626 1629 1699 4121

This examiner grants 65% of resolved cases

Analysis

OTTON, ALICIA L is assigned to Tech Center 4100 and Art Unit 1623. The profile includes 1280 resolved cases, with an allowance rate of 65.0%. Median time to allowance is 959 days, and interview lift is 9.3%. The positive lift indicates that interviews were associated with better allowance outcomes than cases without interviews in the recorded data.

The listed companies are Fortvita Biologics Inc., Hoffmann-La Roche Inc., and Boehringer Ingelheim International GmbH. The listed firms are Apex Attorneys at Law, LLP, ARRIGO, LEE, GUTTMAN & MOUTA-BELLUM LLP, and BakerHostetler. Practitioners can use the substantial case record to establish a working baseline, with interviews and the reported median duration informing response and portfolio planning.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

65.0%
Allow Rate
+5.0% vs TC avg
1,337
Total Applications
+9.3%
Interview Lift
959
Avg Prosecution Days
Based on 1280 resolved cases, 2023–2026

Rejection Statute Breakdown

2.2%
§101 Eligibility
24.0%
§102 Novelty
25.9%
§103 Obviousness
30.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18785078 PROCESS FOR THE MANUFACTURE OF A HER2 INHIBITOR Non-Final OA Boehringer Ingelheim International GmbH
18038511 ORGANIC LIGHT EMITTING DEVICE Non-Final OA LG CHEM, LTD.
18875513 TRIAZINANE COMPOUND AND COMPOSITION CONTAINING SAME Non-Final OA SUMITOMO CHEMICAL COMPANY, LIMITED
18870951 METHOD OF CONTROLLING NEMATODES Non-Final OA ADAMA MAKHTESHIM LTD.
18877636 COMPOSITIONS AND USES OF PSILOCYBIN AND PSILOCIN Non-Final OA ZYLORION HEALTH INC.
18873893 ORGANIC ELECTROLUMINESCENT MATERIAL AND USE THEREOF Non-Final OA GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD
18967641 ANTIFUNGAL AGENTS WITH ENHANCED ACTIVITY IN ACIDIC PH Non-Final OA Scynexis, Inc.
18869941 MACROCYCLIC OREXIN RECEPTOR AGONISTS AND USES THEREOF Non-Final OA Jazz Pharmaceuticals Ireland Limited

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Alicia L Otton's allowance rate?

65.0% of resolved applications examined by Alicia L Otton were allowed (1,280 resolved cases), compared with 51.3% across Art Unit 1623 over the last five years.

Does an interview help with examiner Alicia L Otton?

This examiner's interview lift is +9.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Alicia L Otton take to allow a patent?

Applications allowed by Alicia L Otton took 959 days on average from filing to allowance.

Which art unit does examiner Alicia L Otton work in?

Alicia L Otton examines applications in Art Unit 1623 in Tech Center 4100.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month